Advanced Oncotherapy Plc (AVO)

London
21.25
0.00(0.00%)
  • Volume:
    16,911
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    21.25 - 21.25

AVO Overview

Prev. Close
21.25
Day's Range
21.25-21.25
Revenue
-
Open
21.25
52 wk Range
21.01-42
EPS
-0.08
Volume
16,911
Market Cap
98.46M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
287,554
P/E Ratio
-
Beta
1.6
1-Year Change
-36.57%
Shares Outstanding
466,612,211
Next Earnings Date
27 Jun 2022
What is your sentiment on Advanced Oncotherapy?
or
Market is currently closed. Voting is open during market hours.

Advanced Oncotherapy Plc News

Advanced Oncotherapy Plc Company Profile

Advanced Oncotherapy Plc Company Profile

Advanced Oncotherapy PLC is a United Kingdom-based specialist developer and provider of a proton therapy system, the LIGHT system. The Company is focused on developing and supplying technologies to maximize the destructive effect of radiation on tumors whilst minimizing damage to the patient's healthy tissues. The linear design of LIGHT allows for an active longitudinal modulation along the proton beam axis, and the variation of the proton beam by electronic means during cancer treatment. The feature of LIGHT offers hospitals and treatment centers the flexibility to customize cancer treatment plans based on a range of energies. This could provide an alternative to passive modulation, that degrades the beam along its path, causing it to lose integrity. In addition, a dynamic transversal modulation allows a precise three dimensional (3D) treatment of the tumors via the spot scanning technique.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell